NEW ORAL HEALTH STUDY SEEKING ADULTS AGES 18-59

NEW ORAL HEALTH STUDY SEEKING ADULTS AGES 18-59

Overview

Researchers at the Indiana University School of Dentistry are looking for adults (ages 18-59) to take part in a study on TMD (Temporomandibular Disorder).

Description

Who is eligible
  • Adults ages 18 -59
  • Must be in good general health
  • Must have had head, face, neck and/or shoulder pain for longer than 3 months and are not currently being treated for TMD
  • Must have had no surgery or been recommended surgical treatment for TMD
  • Must not currently wear dentures
  • Must not have started orthodontic treatment during the past 3 months
What is involved
  • You will attend 8 visits over 6 months at the Oral Health Research Institute on the IUPUI campus
  • You will receive the study drug or placebo by injection
  • You will answer questionnaires and receive dental exams
Compensation
  • You will get paid to attend a screening visit ($25) whether you qualify or not
  • You will receive $50 via check for completing each of the seven remaining visits for a total study payment of $375 if you complete the entire study.
How To Participate
If you would like to participate in this study, please submit your information using the provided form below.
 
You may also reach out to the Study Coordinator, Lorena Galvez, directly at (317) 274-8838 or email logalvez@iu.edu

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions: TMD,Temporomandibular Disorder
  • Age: Between 18 Years - 59 Years
  • Gender: Male or Female

Eligibility Criteria
  • Adults ages 18 -59
  • Must be in good general health
  • Must have had head, face, neck and/or shoulder pain for longer than 3 months and are not currently being treated for TMD
  • Must have had no surgery or been recommended surgical treatment for TMD
  • Must not currently wear dentures
  • Must not have started orthodontic treatment during the past 3 months
Additional Information:
Study Title: A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients with Temporomandibular Disorder (CAMG334AUS01T/20-D-242)

Updated on 29 Nov 2022 . Study ID: TX11376

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center